Roughly 37–40% of all new cancer cases in 2022—about 7.1 million—were linked to preventable causes, suggesting major ...

New global analysis from the WHO’s International Agency for Research on Cancer further highlights the opportunity to target ...

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way ...

A total of 30 modifiable risk factors account for almost 40% of new cancer cases globally, a landmark study from the World ...

A landmark global study suggests that tobacco smoking, infection and alcohol consumption are the leading causes of ...

The 30 controllable risk factors that fuel cancer, researchers identify - Preventable cancer is more common in men than women ...

A research group led by The University of Osaka has developed a novel method for analyzing cancer metabolism, revealing new insights into cancer's inefficient energy process. This breakthrough, ...

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...

Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. A sweeping meta-analysis of over 10,000 studies has found that ...